Eleven of the 52 patients 21.2% who did not develop CKD in the first six months following hepatic transplant were treated with tacrolimus immediately following surgery.
De los 52 pacientes que no desarrollaron falla renal crónica a los seis meses de seguimiento, 11 21,2% recibieron tacrolimus en el postrasplante inmediato.